Chemo-Pharma [CPL] vs Equippp Social [EQUIPPP] Detailed Stock Comparison

Chemo-Pharma Laboratories Inc.

BSE
Loading...

Equippp Social Impact Technologies Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 16 metrics, Equippp Social Impact Technologies Ltd. wins in 3 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. Equippp Social Impact Technologies Ltd. Better
P/E Ratio (TTM) 13.22 232.71 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 2.69 19.39 Chemo-Pharma Laboratories Inc.
Debt-to-Equity Ratio 48.02 71.59 Chemo-Pharma Laboratories Inc.
PEG Ratio 0.42 -1.63 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 51.34 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) 6.53% 4.62% Chemo-Pharma Laboratories Inc.
Operating Margin (TTM) 11.52% 4.65% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 11.52% 4.65% Chemo-Pharma Laboratories Inc.
Return on Equity 20.97% -3.72% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 11.26% -1.83% Chemo-Pharma Laboratories Inc.
Free Cash Flow (TTM) $41.66M $-19.15M Chemo-Pharma Laboratories Inc.
1-Year Return -5.34% -4.31% Equippp Social Impact Technologies Ltd.
Price-to-Sales Ratio (TTM) 1.31 4.40 Chemo-Pharma Laboratories Inc.
Enterprise Value $5.40B $1.77B Chemo-Pharma Laboratories Inc.
EV/Revenue Ratio 1.52 4.65 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 24.93% 100.00% Equippp Social Impact Technologies Ltd.
Revenue per Share (TTM) $62 $1 Chemo-Pharma Laboratories Inc.
Earnings per Share (Diluted) $5.81 $0.07 Chemo-Pharma Laboratories Inc.
Beta (Stock Volatility) 0.28 -0.76 Equippp Social Impact Technologies Ltd.

Chemo-Pharma Laboratories Inc. vs Equippp Social Impact Technologies Ltd. Stock Performance Analysis

Loading Price Chart...

CPL
EQUIPPP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
Equippp Social Impact Technologies Ltd.1.14%11.90%25.64%7.63%-15.36%-18.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
Equippp Social Impact Technologies Ltd.-4.31%-29.19%426.00%-42.47%-92.84%-99.78%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs Equippp Social Impact Technologies Ltd.

MetricCPLEQUIPPP
Market Information
Market Cap i₹4.62B₹1.68B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,7005,645
90 Day Avg. Volume i68,6619,349
Last Close₹70.50₹18.62
52 Week Range₹52.67 - ₹87.75₹13.85 - ₹23.97
% from 52W High-19.66%-22.32%
All-Time High₹128.00 (Jan 06, 2025)₹181.15 (Oct 18, 2021)
% from All-Time High-44.92%-89.72%
Growth Metrics
Quarterly Revenue Growth0.40%22.44%
Quarterly Earnings Growth0.41%22.98%
Financial Health
Profit Margin (TTM) i0.07%0.05%
Operating Margin (TTM) i0.12%0.05%
Return on Equity (TTM) i0.21%-0.04%
Debt to Equity (MRQ) i48.0271.59
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹0.84
Cash per Share (MRQ)₹0.05₹0.53
Operating Cash Flow (TTM) i₹277.99M₹-13,950,000
Levered Free Cash Flow (TTM) i₹313.23M₹-4,917,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs Equippp Social Impact Technologies Ltd.

MetricCPL (Apr 26, 2026)EQUIPPP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i13.22232.71
Forward P/E iN/AN/A
PEG Ratio i0.42-1.63
Price to Sales (TTM) i1.314.40
Price to Book (MRQ) i2.6919.39
Market Capitalization
Market Capitalization i₹4.62B₹1.68B
Enterprise Value i₹5.40B₹1.77B
Enterprise Value Metrics
Enterprise to Revenue i1.524.65
Enterprise to EBITDA i13.6051.34
Risk & Other Metrics
Beta i0.28-0.76
Book Value per Share (MRQ) i₹28.58₹0.84

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs Equippp Social Impact Technologies Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)EQUIPPP (2025)
Revenue/Sales i2.85B71.40M
Cost of Goods Sold i2.07B2.50M
COGS % of Revenue i72.6%3.5%
Gross Profit i778.98M68.90M
Gross Margin i27.4%96.5%
Research & Development iN/A64,000
Operating Income (EBIT) i300.69M16.79M
Operating Margin i10.6%23.5%
EBITDA i353.29M19.56M
EBITDA Margin i12.4%27.4%
Pre-Tax Income i392.47M11.26M
Pre-Tax Income % of Revenue i13.8%15.8%
Income Tax i79.24M5.45M
Income Tax % of Revenue i2.8%7.6%
Net Income (Profit) i313.23M5.82M
Profit Margin i11.0%8.1%

Balance Sheet & Liquidity Metrics

MetricCPL (2025)EQUIPPP (2025)
Cash & Equivalents i12.05M49.58M
Total Current Assets i2.51B172.85M
Total Current Assets % of Revenue i88.1%242.1%
Total Current Liabilities i1.17B43.95M
Total Current Liabilities % of Revenue i41.2%61.6%
Long-Term Debt i109.50M88.51M
Long-Term Debt % of Revenue i3.8%124.0%
Total Shareholders Equity i1.49B132.33M
Retained Earnings i1.08B-34.15M
Retained Earnings % of Revenue i37.9%-47.8%
Property, Plant & Equipment i48.61M0

Cash Flow Statement Comparison

MetricCPL (2025)EQUIPPP (2025)
Operating Cash Flow i277.99M-13.95M
Operating Cash Flow % of Revenue i9.8%-19.5%
Capital Expenditures i-47.82M-1.20M
Free Cash Flow i41.66M-19.15M
FCF Margin i1.5%-26.8%
Debt Repayment i-359.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLEQUIPPP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M103.10M
Float Shares i17.41M13.04M
% Held by Insiders i69.98%87.35%
% Held by Institutions i0.00%0.00%
% Held by Public i30.02%12.65%

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs Equippp Social Impact Technologies Ltd.

MetricCPLEQUIPPP
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00₹0.00
Ex-Dividend DateN/AN/A